Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: A meta-analysis

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 20

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. May 28, 2014; 20(20): 6336-6344
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6336

Full Size Figure Download Figure

Figure 1 Flow chart of the study selection process.

Citation: Li J, Gao JZ, Du JL, Wei LX. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2014; 20(20): 6336-6344
URL: https://www.wjgnet.com/1007-9327/full/v20/i20/6336.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i20.6336

Li J, Gao JZ, Du JL, Wei LX. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2014; 20(20): 6336-6344 [PMID: 24876756 DOI: 10.3748/wjg.v20.i20.6336]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.